Aktiesnakken — Juni 2010
-
cash is important to the company
-
han nævnte shareholders interesse (åh jan)
-
super godt!
-
vi tager den senere rth
-
ikke sådan endnu... men se aka's live referat på IR-live som jcbn skriver.
-
Arzerra er helt unik
-
og outperformer alle andre cd20 stoffer i klinikken
-
der er en dropdown boks her i chatvinduet.. der står dansk nu... der kan du også vælge IR-live
-
de tror at Arzerra vil differentiere sig markant fra ritux, i de tilfælde hvor cd20 er lavt udtryk, pga arzerras binding
-
Autoimmune i MS og RA. Et fuldt humaniseret CD20 vil være bedre
-
Han svarer godt. Nervøsiteten er væk
-
Efter sommer vil subcut komme
-
i ra
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind